Skip to main content
Cardiolucent

Condition

Perimenopausal Cardiovascular Risk

Focused cardiovascular assessment for women through perimenopause and beyond.

The perimenopausal years bring substantial cardiovascular change that often goes unaddressed. As estrogen levels decline, women experience shifts in lipid profiles (particularly LDL, triglycerides, and lipoprotein(a)), blood pressure, body composition, glucose tolerance, and arterial stiffness. The result is a notable acceleration of cardiovascular risk that begins well before menopause itself and can be addressed effectively with focused assessment and intervention. Many women present at this stage with new fatigue, palpitations, atypical chest pain, or shortness of breath that deserves a thorough cardiovascular evaluation rather than dismissal as 'just menopause.' Dr. Kedan takes perimenopausal cardiovascular risk seriously and uses this window as an opportunity to reset lifelong cardiovascular trajectory.

What Cardiolucent Evaluates

  • Comprehensive cardiovascular risk assessment with attention to female-specific factors
  • Advanced lipid panel including apolipoprotein B and lipoprotein(a)
  • Blood pressure assessment with home and ambulatory monitoring
  • Echocardiography with POCUS for baseline structural assessment
  • Coronary calcium scoring for risk refinement when indicated
  • Sleep apnea screening, which often emerges or worsens in perimenopause
  • Coordination with primary care and women's health specialists on hormone therapy decisions

Common Symptoms

  • New or worsening fatigue and exercise intolerance
  • Palpitations or awareness of irregular beats
  • Atypical chest pain or pressure, often non-exertional
  • Shortness of breath with activity
  • New onset hypertension
  • Sleep disturbance with snoring or daytime sleepiness
  • Anxiety and mood changes that can overlap with cardiac symptoms

Risk Factors

  • Age in the late 40s through 50s (typical perimenopausal range)
  • Family history of premature cardiovascular disease in female relatives
  • History of pregnancy complications: preeclampsia, gestational diabetes, preterm delivery
  • Premature or surgical menopause
  • Autoimmune disease, more common in women
  • Migraine with aura
  • Smoking, hypertension, diabetes, and traditional risk factors
  • Sedentary lifestyle and weight gain often accelerated in perimenopause

How Cardiolucent Approaches Treatment

Treatment is individualized but typically focuses on aggressive optimization of modifiable risk factors during this window of opportunity: lipid management often becomes appropriate earlier than in pre-menopausal years, blood pressure targets are tighter, sleep apnea screening is essential, and lifestyle intervention is reinforced with extended appointment time. Dr. Kedan also considers female-specific risk factors — a history of preeclampsia, gestational diabetes, or premature menopause all raise cardiovascular risk meaningfully. Coordination with primary care and women's health specialists ensures hormone therapy decisions account for cardiovascular considerations.

Common Questions

Frequently Asked Questions

Why does cardiovascular risk rise during perimenopause?
Declining estrogen during perimenopause affects lipid composition, blood pressure regulation, vascular function, body composition, and glucose metabolism. These changes together accelerate cardiovascular risk in a way that often begins years before menopause itself.
What female-specific risk factors should I know about?
Pregnancy complications — preeclampsia, gestational diabetes, gestational hypertension, preterm delivery — are now recognized cardiovascular risk factors that affect future risk. Premature menopause (before age 40), surgical menopause, autoimmune disease, and migraine with aura also independently raise risk.
Are my symptoms cardiac or hormonal?
Many perimenopausal symptoms overlap with cardiac symptoms: fatigue, palpitations, anxiety, atypical chest pain, shortness of breath. Distinguishing the two often requires objective evaluation rather than assumption. Dr. Kedan evaluates these symptoms thoroughly rather than attributing them prematurely.
Should I be on hormone therapy for cardiovascular protection?
Hormone therapy decisions are individualized and made with women's health expertise. Hormone therapy is not used primarily for cardiovascular prevention. When started for menopausal symptoms in appropriate candidates, the cardiovascular profile is generally favorable in younger postmenopausal women without significant cardiovascular disease. Dr. Kedan participates in these conversations rather than making the decision alone.
When should I have my cholesterol checked?
Lipid panels become particularly important during perimenopause because cholesterol often rises significantly during this transition. Annual or more frequent testing is reasonable, with advanced lipid panels including lipoprotein(a) measured at least once.
What is lipoprotein(a) and why does it matter?
Lipoprotein(a) is a genetically determined particle that independently raises cardiovascular risk. Because it is largely stable through life, most adults benefit from testing at least once, and this is particularly useful in perimenopausal women whose lipid risk is otherwise being newly characterized.
What is the role of coronary calcium scoring?
Coronary calcium scoring can be especially useful in perimenopausal women whose traditional risk calculators may underestimate true risk. A score above zero indicates the presence of coronary plaque and often justifies more aggressive risk reduction; a score of zero is reassuring.
How important are exercise and weight at this stage?
Both become particularly important. Weight gain and loss of muscle mass are common during perimenopause and contribute to insulin resistance, hypertension, and dyslipidemia. Combined aerobic and resistance training, combined with attention to diet quality, provides substantial cardiovascular and metabolic benefit.
What does Cardiolucent do differently for women in this stage?
Dr. Kedan takes perimenopausal cardiovascular symptoms seriously rather than attributing everything to hormones. Extended appointments, POCUS at the visit, and integration of female-specific risk factors into a real cardiovascular plan are standard.
How do I schedule a consultation?
Call (310) 304-5555 or use the contact form to schedule with Dr. Kedan at the Beverly Hills office. Cardiolucent does not bill Medicare or insurance; a detailed superbill is provided for any out-of-network reimbursement.

Explore

Related Conditions

Take advantage of the perimenopausal window.

Schedule a consultation with Dr. Kedan in Beverly Hills.
Schedule an Appointment

Medical Disclaimer

The information on this site is for general educational purposes only and is not medical advice, diagnosis, or treatment. Reading this site does not create a doctor–patient relationship. Always consult a qualified healthcare professional for personal guidance. If this is an emergency, call 911. Mentions of medications, devices, or procedures are informational and not endorsements. Full medical disclaimer.

†Some listed indications involve investigational/off-label use. Learn more.